Akron Healthcare unveils disinfectant tablets to fight COVID-19

19 August 2020 | News

Akrosept manufactured with WHO-approved ingredient & formula

New Delhi based entrepreneur and founder of Akron Healthcare Pvt. Ltd., Arrjun Sehgal has come up with disinfectant tablets by the brand name: Akrosept that is helping people to disinfect a surface, objects, airtight packets, incoming couriers, fruits & vegetables etc. at homes, workplace, clinics, hospitals, restaurants, hotels & religious establishments.

Solution prepared from Akrosept tablets is effective against bacteria, microbes, fungi, germs & viruses including coronavirus. Since April till July 2020, the firm has sold over 14 million Akrosept disinfection tablets. Akrosept tablets carry a 12-year legacy of being a preferred disinfectant amongst leading govt. & private hospitals, nursing homes & clinics.

Sharing more information about the disinfectant tablets, Sehgal, said “While companies were focussing on selling Sanitizers, Masks, PPE and other products, there was no stable disinfectant in the market for protection from COVID-19. We identified this gap and launched Multipurpose Akrosept Tablets on E-Commerce and OTC/Chemist channels to make it accessible to general public for Household & Workplace Disinfection. The formula and active ingredient of Akrosept Powerful Disinfectant Tablets - NaDCC Sodium Dichloroisocyanurate has been recommended by WHO World Health Organisation for Disinfection of High Touch Areas, Surface & Objects to protect against Novel Coronavirus (Covid-19) as part of their Recommended Disease Commodity Package – Novel Coronavirus (nCoV). Akrosept is so far the most stable & superior disinfectant available as compared to Alcohol-Based Disinfectants & Sodium Hypochlorite. It releases stable Hypochlorous Acid in Water & poses no threat of sparking or catching fire like in case of alcohol-based disinfectants.”

Akrosept is competitively priced, more economical & gives value for money in comparison to other disinfectants and sanitizers available in the market.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account